Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Avutometinib in Combination With Defactinib in Metastatic Diffuse Gastric Cancer

NCT06487221 is registered in ClinicalTrials.gov with Ryan H. Moy, MD, PhD as lead sponsor.

NCT NCT06487221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06487221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Avutometinib in Combination With Defactinib in Metastatic Diffuse Gastric Cancer
Lead sponsor
Ryan H. Moy, MD, PhD
Phase
Phase 2
Overall status
Recruiting
Start date
October 28, 2024
Completion date
May 30, 2029
Enrollment
27 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, stomach cancer